Company Overview

Dr. Nagesh Palepu
Founder

Dr. Nagesh Palepu, received prestigious award
from India's Great Scientist Dr. APJ Abdul Kalam

Ex-President, Govt. of India, awarded Dr. Nagesh on 11th March 2013
for his great work in Pharma Research & Development.

IIT, Mumbai facilitated Dr. Nagesh Palepu with Distinguished Alumnus Award.

Over 40 years of commendable experience in NDDs and different dosage forms development. Filed over 8 NDAs, 50 ANDAs on Oral, Parenteral dosage forms and Holder of over 100 International patents and Over 50 US patents Worked with Pfizer, Bristol-Myers, SmithKline Beecham and other companies.

Who We are ?

Therdose, a rapidly rising pharmaceutical firm based in Hyderabad, India's largest pharma and life sciences hub, was founded in 2003 as a knowledge-based pharmaceutical company. TherDose is a differential and generic cancer drugs developer, manufacturer, marketer, and exporter with strong in-house expertise and state-of-the-art R&D facilities.

We are led by a dedicated and enthusiastic team of pharmaceutical professionals with vast experience in manufacturing, engineering, marketing, operations, and finance in both Indian as well as international firms.

Our primary goal at Therdose is to develop and deliver high-quality cancer products that will benefit the worldwide oncology community through technology, innovation, and positive Patient outcomes.

Through our 200+ devoted and experienced employees in R&D, manufacturing, and marketing, we foster a culture of integrity, teamwork, and open communication at Therdose. We are poised for rapid expansion Because of our experience in a range of fields and our ability to combine cutting-edge technology with scientific backing, makes us one of the most exciting place to work.

VISION

To be established as a sustainable Global Player in ONCOLOGY and and differentiated NICHE MOLECULES

MISSION

Achieve our vision through ground breaking research and manufacturing technologies to attain global presence & cGMP competence